foto

Dr. T.M. de Reijke MD PhD

Position
Scientific staff member (UD)
Main activities
Patient care, Research, Teaching
Specialisation
Urology
Focus of research

Uro-oncology (bladder and prostate)

Key publications
  • Sylvester RJ, Brausi MA, Kirkels WJ, Hoeltl W, Calais Da Silva F, Powell PH, Prescott S, Kirkali Z, van de Beek C, Gorlia T, de Reijke TM, Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and high-risk stage Ta T1 urothelial carcinoma of the bladder. EUR UROL 2010;57 (5):766-773 [PubMed]
  • Bolla M, de Reijke TM, van Tienhoven G, van den Bergh ACM, Oddens J, Poortmans PMP, Gez E, Kil P, Akdas A, Soete G, Kariakine O, van der Steen-Banasik EM, Musat E, Piérart M, Mauer ME, Collette L [Contributors: de Reijke TM, van Tienhoven G, van den Bergh ACM, Oddens J, Poortmans PMP, Kil P, van Andel G, van der Steen-Banasik EM, van de Beek C, Schimmel E, Bolla M, Descotes JL, Bosset JF, Hay MH, Bachaud JM, Maingon P, Courdi A, Barillot I, Carrie C, Rothe-Thomas F, Gez E, Akdas A, Lekili M, Soete G, van Poppel H, Vekemans K, van Houtte P, Verbaeys A, Hoekx L, Kariakine O, Cutajar CL, Mirimanoff R, Magrini SM, Busetto M, Bono A, Villa S, Arribas L, Maldonado X, Kynaston H, Barber J, Saxby M, Obralic N]] , Duration of androgen suppression in the treatment of prostate cancer. NEW ENGL J MED 2009;360 (24):2516-2527 [PubMed]
  • Sadri-Ardekani H, Mizrak SC, van Daalen SKM, Korver CM, Roepers-Gajadien HL, Koruji M, Hovingh S, de Reijke TM, de La Rosette JJMCH, van der Veen F, de Rooij DG, Repping S, van Pelt AMM, Propagation of Human Spermatogonial Stem Cells In Vitro. JAMA-J AM MED ASSOC 2009;302 (19):2127-2134 [PubMed]
  • Studer UE, Whelan P, Wimpissinger F, Casselman J, de Reijke TM, Knönagel H, Loidl W, Isorna S, Sundaram SK, Collette L, Differences in time to disease progression do not predict for cancer-specific survival in patients receiving immediate or deferred androgen-deprivation therapy for prostate cancer: final results of EORTC randomized trial 30891 with 12 years of follow-up. EUR UROL 2014;66 (5):829-838 [PubMed]
  • Leyten GHJM, Hessels D, Jannink SA, Smit FP, de Jong H, Cornel EB, de Reijke TM, Vergunst H, Kil P, Knipscheer BC, van Oort IM, Mulders PFA, Hulsbergen-van de Kaa CA, Schalken JA, Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer. EUR UROL 2014;65 (3):534-542 [PubMed]
All Publications
Curriculum Vitae

 1. PERSONAL DATA

Born on October 25, 1952. in Amsterdam, The Netherlands
Citizenship: Dutch

Spoken languages: Dutch, English, German, (French)

Professional Address Academic Medical Center
Department of Urology
Meibergrdreef 9
1105 AZ Amsterdam, The Netherlands
Tel: +31 20 5666004
Fax:+31 20 6919647
e-mail : T.M.deReyke@AMC.UVA.NL


2. MEDICAL EDUCATION

• University
1973 - 1980 Free University, Amsterdam

UROLOGICAL EDUCATION

May 1980-July 1983 General Surgery
Diaconessenhuis Refaja, Dordrecht, The Netherlands
Head: L.N. Nieuwenhuizen

July 1983-July 1986 Onze Lieve Vrouwe Gasthuis,
Amster¬dam. The Netherlands
Head: J.J.M. Bekkers

Academisch Medisch Centrum
Amster¬dam, The Netherlands
Head: Dr. N.F. Dabhoiwala


3. CERTIFICATION :
• Specialist in Urology July 1986
• PhD thesis: Measurable effects of immunotherapy for superficial bladder cancer. 2004

4. SPECIAL "AWARDS" and RECOGNITIONS

2004 Honorary member of the Polish Urological Association

2005 Honorary member of the Asociatia Romana de Urologie

2006 Fellow of the Board of Urology (FEBU)

2009 - Visiting professorship Postgraduate medical school Warsaw


5. BRIEF CHRONOLOGY OF EMPLOYMENT

1986 - Department of Urology Academic Medical Center, Amsterdam

6. MEMBERSHIP AFFILIATION

* Nederlandse Vereniging voor Urologie (1986- )
* American Urological Association (1992- )
* European Association of Urology (1994- )
* Deutsche Gesellschaft für Urologie (1993- )
* Society of Endourology (2000- )
* Full member of the European Organization for Research and Treatment of Cancer
* Member of the Disease Orientated Group Pros¬tate Cancer of the EORTC-GU group (1993-1995)
* Chairman of the Training Programme for Dutch Residents in Urology (1996- )
* Secretary Disease Orientated Group Prostate Cancer of the EORTC-GU group (1995-1999)
* Chairman Disease Orientated Group Prostate Cancer of the EORTC-GU group (1999-2005)
* Secretary of the EORTC-GU group (2005-2006)
* Chairman of the EORTC GU group (2006-2009)
* Member EU-ACME (European Urology – Accredited Continuing Medical Education) (2004-2007)
* Chairman “Guideline Prostate cancer in the Netherlands” (2004-2007)
* Member Education Committee European Board of Urology (1998-2001)
* Chairman Examination Committee European Board of Urology (1998-2007)
* Member Examination Committee European Board of Urology (2007- )


7. SUMMARY OF SCIENTIFIC PRODUCTION

• More than 250 communications and lectures
• More than 200 published abstracts
• Eight published book chapters
• More than 95 published articles (in peer reviewed journals)
 23 as first author
 15 as senior author


 

Research programmes

prostate cancer and bladder cancer daignostics

Faculty
Dr. T.M. de Reijke MD PhD
Drs. A. Meissner MD

PhD Students
Drs. M.T.J. Bus
J.E. Freund
J.W. van Hattum MD MSc
E.I.M.L. Liem
L.A.M.J.G. van Riel MD MSc
Drs. G. Kammeijer (LUMC)

Other research related activities
  • Contribution to guidelines and protocols, prostate cancer
  • Contribution to guidelines and protocols, bladder cancer
Current research funding
  • Astellas Pharma Global Development, Inc.
  • AstraZeneca BV
  • BAYER B.V.
  • Elesta S.r.L.
  • European Association of Urology
  • IQVIA RDS Netherlands B.V.
  • Janssen Cilag B.V.
  • Personeelsproject - Industrie
  • PPD Global Ltd
  • Stichting Cure for Cancer
  • Syneos Health UK Limited